Scott W. Henggeler, PhD, and Ashli J. Sheidow, PhD, Family Services Research Center, Medical University of South Carolina.
Empirically Supported Family-Based Treatments for Conduct Disorder and Delinquency in Adolescents
Article first published online: 20 SEP 2011
© 2011 American Association for Marriage and Family Therapy
Journal of Marital and Family Therapy
Volume 38, Issue 1, pages 30–58, January 2012
How to Cite
Henggeler, S. W. and Sheidow, A. J. (2012), Empirically Supported Family-Based Treatments for Conduct Disorder and Delinquency in Adolescents. Journal of Marital and Family Therapy, 38: 30–58. doi: 10.1111/j.1752-0606.2011.00244.x
This article was supported by grants DA019892, DA017487, and DA019708 to the first author from the National Institute on Drug Abuse as well as a grant from the Annie E. Casey Foundation; and grant DA025616 from the National Institute on Drug Abuse to the second author.
The first author is a board member and stockholder of MST Services, LLC, the Medical University of South Carolina–licensed purveyor organization that provides training in MST.
- Issue published online: 27 JAN 2012
- Article first published online: 20 SEP 2011
Several family-based treatments of conduct disorder and delinquency in adolescents have emerged as evidence-based and, in recent years, have been transported to more than 800 community practice settings. These models include multisystemic therapy, functional family therapy, multidimensional treatment foster care, and, to a lesser extent, brief strategic family therapy. In addition to summarizing the theoretical and clinical bases of these treatments, their results in efficacy and effectiveness trials are examined with particular emphasis on any demonstrated capacity to achieve favorable outcomes when implemented by real-world practitioners in community practice settings. Special attention is also devoted to research on purported mechanisms of change as well as the long-term sustainability of outcomes achieved by these treatment models. Importantly, we note that the developers of each of the models have developed quality assurance systems to support treatment fidelity and youth and family outcomes; and the developers have formed purveyor organizations to facilitate the large-scale transport of their respective treatments to community settings nationally and internationally.